Loading
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (1 ops.)
Latest filing published 24 Feb 2017 for DERMA SCIENCES, INC..
Insider track record
Disclosed buys
7
Disclosed sells
1
Signal history
No signal scores available.
Closed purchases
Market purchases
7
Positive at T+90
0%
Median T+90
-8.5%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +3.0%Entry US$15.49 · Close at T+365 US$15.95
- -12.6%Entry US$17.00 · Close at T+365 US$14.85
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert G. Moussa: trading record in brief
This profile gathers the share dealings of Robert G. Moussa across 3 companies, led by Derma Sciences, Inc., CALMARE THERAPEUTICS Inc and Daxor Corp. Over a trading history stretching from 16 June 2006 to 24 February 2017, the count stands at 24 filings.
The open-market side counts 7 purchases for €149.9M alongside 1 sale for €46k. Taken together, the purchases exceed the sales by €149.8M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 11 share grants and 3 option exercises.
A typical purchase (the median) is worth €7,054.
On 24 February 2017 came the latest disclosure, a transaction in Derma Sciences, Inc. The clock since the last published purchase (14 August 2015) now reads 4,088 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert G. Moussa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
81,771 sharesCommon StockSEC:0001144204-17-011006:0
17,500 sharesCommon StockSEC:0001144204-17-011006:1
4,375 shares@ US$6.40100.0% of flowCommon StockSEC:0001144204-17-009663:0
17,500 shares0Common StockSEC:0001144204-16-106816:0
5,000 shares@ US$6.61Common StockSEC:0001144204-15-049873:0
Canonical exit: 11 Nov 2015 (T+90)
10,000 shares0Common StockSEC:0001144204-15-034573:0
2,500 shares0Common StockSEC:0001615774-15-001148:0
11,250 shares@ US$3.36Common StockSEC:0001144204-15-017575:0
4,604 shares@ US$8.21Common StockSEC:0001144204-15-017575:1
2,500 shares0Common StockSEC:0001144204-14-041443:0
7,750 shares0Common StockSEC:0001144204-14-033513:0
6,500 shares0Common StockSEC:0001144204-13-031843:0
15,000 shares0Common StockSEC:0001088020-12-000067:0
3,000 shares0Common StockSEC:0001088020-12-000037:0
2,500 shares0Common StockSEC:0001088020-12-000030:0
5,000 shares@ US$12.60common stockSEC:0001088020-11-000011:0
25,000 shares0common stockSEC:0001088020-09-000031:0
20,000 shares@ US$10,800.00common stockSEC:0001088020-08-000049:0
Canonical exit: 18 Dec 2008 (T+90)
7,500 shares@ US$0.64common stockSEC:0001088020-07-000059:0
Canonical exit: 2 Mar 2008 (T+90)
12,500 shares@ US$0.65common stockSEC:0001088020-07-000059:1
Canonical exit: 2 Mar 2008 (T+90)
500 shares@ US$15.29Daxor Common StockSEC:0001169232-06-004214:0
Canonical exit: 29 Jan 2007 (T+90)
15,000 shares@ US$0.74common stockSEC:0001088020-06-000057:0
Canonical exit: 28 Nov 2006 (T+90)
500 shares@ US$17.84DAXOR COMMON STOCKSEC:0001169232-06-002811:0
Canonical exit: 14 Sept 2006 (T+90)
23 of 23 declarations
